Zobrazeno 1 - 10
of 607
pro vyhledávání: '"Tom Li"'
Autor:
Caterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Nanna Brix Finnerup, Luis Garcia-Larrea, Tom Li, Marcus Goetz, André Mouraux, Bernhard Pelz, Esther Pogatzki-Zahn, Andreas Schilder, Erik Schnetter, Karin Schubart, Irene Tracey, Inaki F. Troconiz, Hans Van Niel, Jose Miguel Vela Hernandez, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Keith G. Phillips, Andrea Truini, Rolf-Detlef Treede
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-26 (2022)
Abstract Background IMI2-PainCare-BioPain-RCT2 is one of four similarly designed clinical studies aiming at profiling a set of functional biomarkers of drug effects on specific compartments of the nociceptive system that could serve to accelerate the
Externí odkaz:
https://doaj.org/article/ee7c96a2132b40cebc8ecb1b9816874f
Publikováno v:
ANZ Journal of Surgery. 93:76-82
Autor:
Ian Harris, Aidan Christopher Tan, Sam Adie, Marina Pinheiro, Justine M Naylor, Zet Wei Tan, Tom Li, Michiel Siebelt, Jasper van Tiel, Laura Harris, Kira Chamberlain
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Objectives To determine the reporting quality of published randomised controlled trial (RCT) protocols before and after the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement (2013), and any association with author,
Externí odkaz:
https://doaj.org/article/93e3ae841ff245c29dc1557ce01f3cb3
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237691 (2020)
Efficient strategies to contain the coronavirus disease 2019 (COVID-19) pandemic are peremptory to relieve the negatively impacted public health and global economy, with the full scope yet to unfold. In the absence of highly effective drugs, vaccines
Externí odkaz:
https://doaj.org/article/dc7f61b732884806a01b07d33654b033
Publikováno v:
Lecture Notes in Mechanical Engineering ISBN: 9783031288388
Fighting counterfeit drugs in pharma logistics networks, is one of the most important challenges in the industry. In order to contribute to the UN Sustainable Development Goal of “global health and well-being” the integration of counterfeit subst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ddc9ea1fdea59148e673128b887a969d
https://doi.org/10.1007/978-3-031-28839-5_71
https://doi.org/10.1007/978-3-031-28839-5_71
Publikováno v:
Cancer Research. 83:3110-3110
Transducin β-like protein 1 (TBL1) is an essential scaffold protein that participates in multiple critical signaling pathways, such as the Wnt/β-catenin pathway, where it protects β-catenin from ubiquitination and proteasomal degradation. Only one
Autor:
Tom Li Stephen, Qian Zhang, Byung-Kwon Lee, Chao Kong, Rain Sun, Jia Wu, Jie Cui, Hillary Shah, Wenhua Xu, Yun-Yueh Lu, Joshua Whitener, Emily Jackson, Jinping Gan, Francisco Adrian, Liang Schweizer
Publikováno v:
Cancer Research. 83:3477-3477
The CD226 (DNAM-1) axis has emerged as an important immune-modulatory pathway that regulates T cell and NK cell effector functions in the solid tumor microenvironment. Three inhibitory receptors, TIGIT, CD96, and PVRIG, inhibit the activating recepto
Autor:
Rahul Menon, Tom Li, Andy Wang, Sam Adie, Marina B. Pinheiro, Justine M. Naylor, Ian A. Harris, Kira Chamberlain, Laura Harris
Publikováno v:
ANZ Journal of Surgery. 91:2014-2020
Background Clinical trials should ideally use patient-important outcomes to ensure their results are clinically relevant. We aimed to determine if the proportion of patient-important outcomes in surgical trials has changed over the last decade, and t
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2012 May 01. 109(19), 7415-7420.
Externí odkaz:
https://www.jstor.org/stable/41593029
Autor:
Caterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, Petra Bloms-Funke, Irmgard Boesl, Ombretta Caspani, Sonya C. Chapman, Nanna Brix Finnerup, Luis Garcia-Larrea, Tom Li, Marcus Goetz, André Mouraux, Bernhard Pelz, Esther Pogatzki-Zahn, Andreas Schilder, Erik Schnetter, Karin Schubart, Irene Tracey, Inaki F. Troconiz, Hans Van Niel, Jose Miguel Vela Hernandez, Katy Vincent, Jan Vollert, Vishvarani Wanigasekera, Matthias Wittayer, Keith G. Phillips, Andrea Truini, Rolf-Detlef Treede
Publikováno v:
Leone, C, Di Stefano, G, Di Pietro, G, Bloms-Funke, P, Boesl, I, Caspani, O, Chapman, S C, Finnerup, N B, Garcia-Larrea, L, Li, T, Goetz, M, Mouraux, A, Pelz, B, Pogatzki-Zahn, E, Schilder, A, Schnetter, E, Schubart, K, Tracey, I, Troconiz, I F, Van Niel, H, Hernandez, J M V, Vincent, K, Vollert, J, Wanigasekera, V, Wittayer, M, Phillips, K G, Truini, A & Treede, R D 2022, ' IMI2-PainCare-BioPain-RCT2 protocol : a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity ', Trials, vol. 23, no. 1, 739 . https://doi.org/10.1186/s13063-022-06431-5
Background IMI2-PainCare-BioPain-RCT2 is one of four similarly designed clinical studies aiming at profiling a set of functional biomarkers of drug effects on specific compartments of the nociceptive system that could serve to accelerate the future d